Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
BackgroundHepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide. PAFAH1B3 plays an important role on occurrence and development in a variety tumor. However, the function of PAFAH1B3 in HCC remains unclear.MethodsThe TIMER, ONCOMINE, Human Protein Atlas (HPA),...
Main Authors: | Weikang Xu, Xinyu Lu, Jing Liu, Qianhui Chen, Xuan Huang, Kuiyuan Huang, Hongyan Liu, Wei Zhu, Xiaoyong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.700700/full |
Similar Items
-
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
by: Chen, B., et al.
Published: (2022) -
PAFAH1B3 Expression Is Correlated With Gastric Cancer Cell Proliferation and Immune Infiltration
by: Tianyu Xie, et al.
Published: (2021-02-01) -
An isolated case of lissencephaly caused by the insertion of a mitochondrial genome-derived DNA sequence into the 5' untranslated region of the <it>PAFAH1B1 </it>(LIS1) gene
by: Millar David S, et al.
Published: (2010-08-01) -
Prenatal diagnosis of a 0.7-Mb 17p13.3 microdeletion encompassing YWHAE and CRK but not PAFAH1B1 in a fetus without ultrasound abnormalities
by: Chih-Ping Chen, et al.
Published: (2018-02-01) -
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01)